Susanna Hegewisch-Becker

64PUBLICATIONS
300CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Aug 17, 2026
Identification of key symptoms impacting HRQOL in advanced renal cell carcinoma: nivolumab plus cabozantinib versus sunitinib in CheckMate 9ER.

|Jul 29, 2026
Complete response to dual immune checkpoint blockade in a patient with Birt-Hogg-Dubé syndrome and epithelioid angiomyolipoma.

|Mar 30, 2026
Cardiac biomarkers in patients with renal cell carcinoma treated with immune checkpoint inhibitors.

Yen-Chou Chen, Mandar A Aras, Brian I Rini

|Feb 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors.

Sophie A Hanina, Tyler Park, Michael Lopez

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Oct 13, 2025
Postimmunotherapy and Vascular Endothelial Growth Factor Inhibitor Landscape in Advanced Renal Cell Carcinoma: Treatment Patterns, Costs, and Outcomes.

Neil J Shah, Reshma Shinde, Rituparna Bhattacharya

Pageof 11

Frequent Collaborators

22 joint publications

Martin H Voss

16 joint publications

Toni K Choueiri

13 joint publications

Ritesh R Kotecha

10 joint publications

Chung-Han Lee